1. |
Nash GF, Turner LF, Scully MF, et al. Platelets and cancer[J]. Lancet Oncol, 2002, 3(7): 425-430.
|
2. |
Makrilia N, Lappa T, Xyla V, et al. The role of angiogenesis in solid tumours: an overview[J]. Eur J Intern Med, 2009, 20(7): 663-671.
|
3. |
Zhang J, Ito R, Oue N, et al. Expression of thrombospondin-1 is correlated with microvessel density in gastric carcinoma[J]. Virchows Arch, 2003, 442(6): 563-568.
|
4. |
Byrne GJ, Hayden KE, McDowell G, et al. Angiogenic characteristics of circulating and tumoural thrombospondin-1 in breast cancer[J]. Int J Oncol, 2007, 31(5): 1127-1132.
|
5. |
Monreal M, Fernandez-Llamazares J, Piñol M, et al. Platelet count and survival in patients with colorectal cancer-a preliminary study[J]. Thromb Haemost, 1998, 79(5): 916-918.
|
6. |
吕东昊, 汪晓东, 阳川华, 等.结直肠肿瘤多学科协作诊治模式的数据库初期建设现状[J].中国普外基础与临床杂志, 2007, 14(6): 713-715.
|
7. |
Bilous M, Osamura RY, Rüschoff J, et al. HER-2 amplification is highly homogenous in gastric cancer[J]. Hum Pathol, 2010, 41(2): 304-305.
|
8. |
Pinedo HM, Verheul HM, D'Amato RJ, et al. Involvement of platelets in tumour angiogenesis?[J]. Lancet, 1998, 352(9142): 1775-1777.
|
9. |
Hippo Y, Yashiro M, Ishii M, et al. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes[J]. Cancer Res, 2001, 61(3): 889-895.
|
10. |
Wang YD, Wu P, Mao JD, et al. Relationship between vascular invasion and microvessel density and micrometastasis[J]. World J Gastroenterol, 2007, 13(46): 6269-6273.
|
11. |
Lawler PR, Lawler J. Molecular basis for the regulation of angiogenesis by thrombospondin-1 and-2[J]. Cold Spring Harb Perspect Med, 2012, 2(5): a006627.
|
12. |
刘元波, 赵相印.肿瘤所致凝血异常的研究进展[J].首都医科大学学报, 2000, 21(3): 270-272.
|
13. |
陈静, 支宇, 常晓静, 等.血小板反应素-1在胃癌及转移淋巴结中的表达及其与血管生成相关性的研究[J].中国普外基础与临床杂志, 2013, 20(11): 1257-1262.
|
14. |
Muhammadnejad S, Muhammadnejad A, Haddadi M, et al. Correlation of microvessel density with nuclear pleomorphism, mitotic count and vascular invasion in breast and prostate cancers at preclinical and clinical levels[J]. Asian Pac J Cancer Prev, 2013, 14(1): 63-68.
|
15. |
Armstrong LC, Bornstein P. Thrombospondins 1 and 2 function as inhibitors of angiogenesis[J]. Matrix Biol, 2003, 22(1): 63-71.
|
16. |
Dymicka-Piekarska V, Kemona H, Piotrowski Z, et al. Does colorectal cancer influence platelet activation?[J]. Przegl Lek, 2003, 60(11): 716-718.
|
17. |
甘志明, 马琛, 李立, 等. TNM分期对直肠/肛管癌患者结肛吻合术后近期疗效的影响[J].西部医学, 2012, 24(9): 1705-1708.
|
18. |
Cushman M. Epidemiology and risk factors for venous thrombosis[J]. Semin Hematol, 2007, 44(2): 62-69.
|
19. |
Sierko E, Wojtukiewicz MZ. Inhibition of platelet function: does it offer a chance of better cancer progression control?[J]. Semin Thromb Hemost, 2007, 33(7): 712-721.
|
20. |
Miyazaki T, Okada N, Ishibashi K, et al. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer[J]. Jpn J Clin Oncol, 2008, 38(12): 839-843.
|
21. |
Kisucka J, Butterfield CE, Duda DG, et al. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage[J]. Proc Natl Acad Sci USA, 2006, 103(4): 855-860.
|
22. |
Brockmann MA, Giese A, Mueller K, et al. Preoperative thrombocytosis predicts poor survival in patients with glioblastoma[J]. Neuro Oncol, 2007, 9(3): 335-342.
|
23. |
Salgado R, Vermeulen PB, Benoy I, et al. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients[J]. Br J Cancer, 1999, 80(5/6): 892-897.
|
24. |
Sasaki K, Kawai K, Tsuno NH, et al. Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer[J]. World J Surg, 2012, 36(1): 192-200.
|
25. |
Ferroni P, Spila A, D'Alessandro R, et al. Platelet activation and vascular endothelial growth factor 165 release in hepatocellular cancer[J]. Clin Chim Acta, 2011, 412(5/6): 450-454.
|